ALBANY MOLECUL RESH (NASDAQ:AMRI)
8.30
+0.16 (1.97%)
| ALBANY MOLECUL RESH (NASDAQ:AMRI) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $8.14 | 52 Week High | $12.56 | ||
| Open | $8.07 | 52 Week Low | $7.31 | ||
| Day High | $8.35 | P/E | 43.68 | ||
| Day Low | $8.07 | EPS | $0.19 | ||
| Volume | 134,838 | ||||
| More AMRI Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| SCLN | 3 | MTL | 2 |
| TNS | 2 | WFMI | 2 |
| XRM | 2 | DIVX | 2 |
| CHDX | 2 | APEI | 2 |
| DVAX | 2 | BBND | 1 |
| CF | 1 | ATAI | 1 |
Entities who have mentioned AMRI
- Jefferies & Co | View Related Stories »
- Matrix USA | View Related Stories »
- 13G | View Related Stories »
- Scopia Capital | View Related Stories »
- Morgan Stanley | View Related Stories »
- After-Hours Movers | View Related Stories »
- Citi | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Treasury Capital Purchase Program | View Related Stories »
- William Blair | View Related Stories »
- HSBC | View Related Stories »
- Trading Radar | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Merrill Lynch | View Related Stories »
- Dividend | View Related Stories »
View All Major News StreetInsider.com Major News for AMRI
- Albany Molecular Research (AMRI) Posts Q3 Loss of $0.02, Tops by 2c; Guides
- Albany Molecular Research (AMRI) Misses Q2 EPS by 5c; Guides Below for Q3 and FY Revenues
- AMRI (AMRI) Swings to Q4 Profit; Guides Q1, FY09
View All ReportsStreetInsider.com Reports on AMRI
- Albany Molecular Research (AMRI) Posts Q3 Loss of $0.02, Tops by 2c; Guides
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- AMRI Files New Patent Infringement Lawsuits against Dr. Reddy's Laboratories (RDY) and Sandoz
- Morning Movers 8/5: ONT, CMLS, INO, RDN, SCLN, PRAN, NVAX Higher; XRM, CVGI, VCLK, ACAS, SXE, AMRI, GCA Lower
- After-Hours Movers 8/4: SCLN, PLNR, DVAX, HYC, PODD, WFMI Higher; BBND, XRM, GUID, FBN, DIVX, APEI Lower
View All Press ReleasesCompany Press Releases on AMRI
- AMRI Announces Third Quarter 2009 Results
- Third Compound from AMRI Bristol-Myers Squibb Collaboration Selected for Preclinical Development
- AMRI to Present at the Oppenheimer 20th Annual Healthcare Conference
- AMRI to Announce Third Quarter Results
StreetInsider Reports on AMRI by Category
View All BlogsBlogs on AMRI
- 19 'Bathwater Babies' and 20 'Dogs with Fleas' Stocks for the Week
- Analyst upgrades, downgrades and initiations
- Albany Molecular Research, Inc. Q2 2008 Earnings Call Transcript
- Earnings highlights: Wal-Mart, JCPenney, MBIA, Deere, Applied Materials and others
- Albany Molecular Research (AMRI): Stock price consolidating in bullish 'pennant'
View All FilingsSEC Filings on AMRI
- Form 4 ALBANY MOLECULAR RESEARC For: Nov 19 Filed by: Hagen Steven R
- Form 4 ALBANY MOLECULAR RESEARC For: Nov 16 Filed by: Hagen Steven R
- Form 10-Q ALBANY MOLECULAR RESEARC For: Sep 30
- Form 8-K ALBANY MOLECULAR RESEARC For: Nov 09
- Form SC 13G ALBANY MOLECULAR RESEARC Filed by: BROWN CAPITAL MANAGEMENT INC
Comments on AMRI
No comments are currently available.
